Woman-Health Focused Stock Agile Therapeutics Is ‘Better Positioned,’ Analyst Says While Upgrading Stock
Maxim Group upgraded Agile Therapeutics Inc (NASDAQ:AGRX) to Buy from Hold with a price target of $1, saying it should be…
House Now Voting On Legislation That Would Enshrine Federal Protection Of Access To Contraceptives Without Government Restrictions Into Law
https://twitter.com/CraigCaplan/status/1550143822281297920
HC Wainwright Sees Agile Therapeutics’ Twirla Tailwinds Post Roe-Wade Ruling
Agile Therapeutics Inc's (NASDAQ: AGRX) Twirla, the only low-dose transdermal hormonal contraceptive, should have tailwinds protected after the Supreme Court overturned Roe vs. Wade ruling that legalized abortion nationwide.
Agile Therapeutics Says Expects Q2 Twirla Demand To Be 21,000-21,500 Cycles
Twirla® Demand Guidance (Total Cycles) Expected to be at Midpoint of Guided Range
Operating Expenses (OPEX) Expected to be Below Guided Range
PRINCETON, N.J., July 12, 2022 (GLOBE NEWSWIRE) --
President Biden Mulls Health Emergency For Abortion Access: Report
U.S. President Joe Biden said he had asked his administration to consider whether he has the authority to…
